WCD: Ustekinumab succeeds as switch agent in psoriasis
VANCOUVER, B.C. – When adults with moderate to severe psoriasis fail one anti-TNF agent, most will still respond to another anti-TNF or ustekinumab, according to data from an investigation...
Source: Skin and Allergy News - Category: Dermatology Tags: RHEUM Conference News SAN Conference News RHEUM News RHEUM Spondyloarthropathies SAN Clinical News SAN News SAN Psoriasis RHEUM Psoriatic arthritis Source Type: news
More News: Allergy | Allergy & Immunology | Arthritis | Conferences | Dermatology | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin | Stelara